eMedicine Specialties > Pediatrics: General Medicine > Nephrology

Renal Cortical Necrosis: Treatment & Medication

Author: Elif Erkan, MD, Assistant Professor, Department of Pediatrics, Division of Pediatric Nephrology, University of Rochester School of Medicine
Coauthor(s): Prasad Devarajan, MD, Louise M Williams Endowed Chair in Pediatrics, Professor of Pediatrics and Developmental Biology, Director of Nephrology and Hypertension, Director of Clinical Nephrology Laboratories, Chief Executive Officer of Dialysis Unit, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine
Contributor Information and Disclosures

Updated: Dec 13, 2007

Treatment

Medical Care

  • The cornerstones of therapy are to restore hemodynamic stability, institute early dialytic therapy, and treat the underlying cause.
  • Most cases initially require intensive care.
  • Restoration of hemodynamic stability may require use of IV crystalloids, colloids, blood products, and/or pressors to maintain blood pressure and cardiac output.
  • Early institution of dialysis treatment for renal failure is crucial for patients who are oliguric. Refer to relevant chapters for medical management of acute renal failure, including Hyperkalemia, fluid overload, and Acidosis, Metabolic.

Surgical Care

  • Most patients require an access (eg, hemocatheter, peritoneal dialysis catheter) to institute dialysis.

Consultations

  • Consult a pediatric nephrologist to manage acute renal failure and for ongoing chronic renal replacement therapy.
  • Consultation with other specialties may be needed, depending on the etiology of the renal cortical necrosis (RCN).

Diet

  • Ensure adequate energy intake.
  • Patients with compromised kidney function require a low-potassium, low-phosphorus diet.

Activity

Activity should continue as tolerated.

More on Renal Cortical Necrosis

Overview: Renal Cortical Necrosis
Differential Diagnoses & Workup: Renal Cortical Necrosis
Treatment & Medication: Renal Cortical Necrosis
Follow-up: Renal Cortical Necrosis
References
[ CLOSE WINDOW ]

References

  1. Prakash J, Vohra R, Wani IA, et al. Decreasing incidence of renal cortical necrosis in patients with acute renal failure in developing countries: a single-centre experience of 22 years from Eastern India. Nephrol Dial Transplant. Apr 2007;22(4):1213-7. [Medline].

  2. Kamioka I, Nozu K, Fujita T, et al. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome. Pediatr Int. Apr 2007;49(2):196-201. [Medline].

  3. Ali BH, Al-Qarawi AA, Mahmoud OM, Hashad M. Influence of spironolactone treatment on gentamicin-induced nephrotoxicity in rats. Basic Clin Pharmacol Toxicol. Jul 2004;95(1):20-3. [Medline].

  4. Ali SS, Rizvi SZ, Muzaffar S, et al. Renal cortical necrosis: a case series of nine patients & review of literature. J Ayub Med Coll Abbottabad. Apr-Jun 2003;15(2):41-4. [Medline].

  5. Chugh KS, Jha V, Sakhuja V, Joshi K. Acute renal cortical necrosis--a study of 113 patients. Ren Fail. 1994;16(1):37-47. [Medline].

  6. Hashimoto S, Shiroshita K, Sakurai T, et al. Unilateral renal cortical necrosis with contralateral hydronephrosis after surgery for uterus carcinoma. Clin Exp Nephrol. Mar 2003;7(1):72-6. [Medline].

  7. Lerner GR, Kurnetz R, Bernstein J, et al. Renal cortical and renal medullary necrosis in the first 3 months of life. Pediatr Nephrol. Nov 1992;6(6):516-8. [Medline].

  8. Mertens PR, Duque-Reina D, Ittel TH, et al. Contrast-enhanced computed tomography for demonstration of bilateral renal cortical necrosis. Clin Investig. Jul 1994;72(7):499-501. [Medline].

  9. Racusen LC, Solez K. Renal infarction, cortical necrosis, and atheroembolic disease. In: Tisher CC, Brenner BM, eds. Renal Pathology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1994:810-31.

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

renal cortical necrosis, RCN, acute renal failure, acute renal failure in pregnancy, kidney failure, dehydration, placental abruption, ischemic necrosis of the renal cortex, renal arterial perfusion, acute tubular necrosis, hemolytic uremic syndrome, HUS, septic abortion, acute renal failure, oliguria, hematuria, perinatal asphyxia, cyanotic heart disease, eclampsia, hypotension, congenital heart disease, anemia, hemolytic disease, gastroenteritis

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Elif Erkan, MD, Assistant Professor, Department of Pediatrics, Division of Pediatric Nephrology, University of Rochester School of Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Prasad Devarajan, MD, Louise M Williams Endowed Chair in Pediatrics, Professor of Pediatrics and Developmental Biology, Director of Nephrology and Hypertension, Director of Clinical Nephrology Laboratories, Chief Executive Officer of Dialysis Unit, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine
Prasad Devarajan, MD is a member of the following medical societies: American Heart Association, American Society of Nephrology, American Society of Pediatric Nephrology, National Kidney Foundation, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Medical Editor

Laurence Finberg, MD, Clinical Professor, Department of Pediatrics, University of California at San Francisco and Stanford University
Laurence Finberg, MD is a member of the following medical societies: American Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

Luther Travis, MD, William W Glauser Professor of Pediatrics and Pediatric Nephrology, Department of Pediatrics, Divisions of Nephrology and Diabetes, University of Texas Medical Branch and Children's Hospital
Luther Travis, MD is a member of the following medical societies: Alpha Omega Alpha, American Federation for Medical Research, International Society of Nephrology, and Texas Pediatric Society
Disclosure: Nothing to disclose.

CME Editor

Howard Trachtman, MD, Program Director, Pediatrics Research, Schneider Children's Hospital, Department of Pediatrics, Division of Nephrology, Professor, Albert Einstein College of Medicine
Howard Trachtman, MD is a member of the following medical societies: American Society of Hypertension, American Society of Nephrology, American Society of Pediatric Nephrology, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Chief Editor

Craig B Langman, MD, The Isaac A Abt, MD, Professor of Kidney Diseases, Feinberg School of Medicine, Northwestern University; Division Head of Kidney Diseases, Children's Memorial Hospital, Chicago
Craig B Langman, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Nephrology, and International Society of Nephrology
Disclosure: Amgen Grant/research funds None; Abbott Honoraria Speaking and teaching; Altus Pharmaceuticals Grant/research funds None; Genzyme Grant/research funds None; Merck Grant/research funds None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.